Author's reply - Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

EClinicalMedicine. 2022 Aug 27:52:101617. doi: 10.1016/j.eclinm.2022.101617. eCollection 2022 Oct.

¹ Centre for Recurrent Pregnancy Loss, Teine Keijinkai Hospital, 1-40 Maeda 1-jho 12-chome Teine-ku, Sapporo, Japan.
² Department of Obstetrics and Gynecology, Kobe University School of Medicine, 7-5-1 Kusunoki-cho Chuo-ku, Kobe, Japan.
³ Department of Obstetrics and Gynecology, University of Toyama, 2630 Sugitani, Toyama, Japan.
⁴ Department of Obstetrics and Gynecology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, Japan.

No abstract available